Title
Category
Credits
Event date
Cost
  • Basic and Translational Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 4: Vascular Regeneration, Stem Cells, and Wound Healing.
  • Basic and Translational Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 4: Vascular Regeneration, Stem Cells, and Wound Healing. 
  • Basic and Translational Research
  • Aortic Aneurysm Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 3: Aortopathies and Novel Vascular Devices. Knowledge StrategyTrauma TEVAR is associated with LV mass increase, development of hypertension, and off-target accelerated expansile ascending aortic remodeling. Our findings call for better follow-up of young patients receiving stent-grafts and for improved endovascular devices capable of preserving optimal ventricular-arterial coupling.
  • Basic and Translational Research
  • Aortic Aneurysm Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 3: Aortopathies and Novel Vascular Devices. Knowledge StrategyThere currently exists no successful medical management of abdominal aortic aneurysms. This research helps to identify potential therapeutic targets and mechanisms in the treatment of this disease.Professional Practice GapThis research addresses potential medical therapies in the treatment of AAA as currently operative intervention remains the only definitive treatment.
  • Basic and Translational Research
  • Translational Science Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 3: Aortopathies and Novel Vascular Devices. Knowledge Strategy Develop new diagnostic and treatment modalities for AAAProfessional Practice Gap Experimental AAA models are subacute.
  • Basic and Translational Research
  • Translational Science Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 3: Aortopathies and Novel Vascular Devices.Knowledge StrategyThis study demonstrated that BTK inhibitor ibrutinib, FDA-approved drug, attenuated the formation of, and further progression of established, experimental AAAs in two mechanistically distinct but complementary AAA model systems. Our results suggest that pharmacological inhibition of BTK may represent a novel translational strategy for AAA disease suppression.
  • Basic and Translational Research
  • Aortic Aneurysm Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 3: Aortopathies and Novel Vascular Devices. 
  • Basic and Translational Research
  • Ischemia
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 4: Vascular Regeneration, Stem Cells, and Wound Healing. Knowledge StrategyWe attempt to increase stem cell's inherent therapeutic potential with a novel vector to increase cell's homing capabilities and overall potency.
  • Basic and Translational Research
  • Ischemia
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 4: Vascular Regeneration, Stem Cells, and Wound Healing. 
  • Basic and Translational Research
  • Aortic Aneurysm Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 4: Vascular Regeneration, Stem Cells, and Wound Healing. Knowledge Strategy We may opt to treat patients with claudication more aggressively.Professional Practice Gap Resting perfusion to muscle in PAD may cause long term effects beyond schema and may alter how disease should be managed.

Pages